Celcuity
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celcuity and other ETFs, options, and stocks.About CELC
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies.
CEOBrian F. Sullivan
CEOBrian F. Sullivan
Employees87
Employees87
HeadquartersMinneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded2012
Founded2012
Employees87
Employees87
CELC Key Statistics
Market cap3.14B
Market cap3.14B
Price-Earnings ratio-21.47
Price-Earnings ratio-21.47
Dividend yield—
Dividend yield—
Average volume1.94M
Average volume1.94M
High today$75.69
High today$75.69
Low today$71.61
Low today$71.61
Open price$74.50
Open price$74.50
Volume562.47K
Volume562.47K
52 Week high$83.00
52 Week high$83.00
52 Week low$7.58
52 Week low$7.58
CELC News
TipRanks 2d
Celcuity Inc.’s Promising Phase 3 Breast Cancer Study: A Market Game-Changer?Celcuity Inc. ((CELC)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...
TipRanks 3d
Celcuity Inc.’s Promising Study on mCRPC Treatment: Key Insights for InvestorsCelcuity Inc. ((CELC)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Un...
Simply Wall St 4d
A Look at Celcuity Valuation Following Phase 3 Breast Cancer and Prostate Cancer Trial ResultsCelcuity (NasdaqCM:CELC) delivered a packed update for investors, unveiling fresh results from its VIKTORIA-1 Phase 3 breast cancer trial and new data on its pr...
Analyst ratings
100%
of 9 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CELC. This list is generated using Robinhood data, and it’s not a recommendation.